Review Suggests Oral Campylobacter Species Has Indicators For IBD

Review Suggests Oral Campylobacter Species Has Indicators For IBD
In a recent review published in the World Journal of Gastroenterology,  Li Zhang from the School of Biotechnology and Biomolecular Sciences, University of New South Wales in Australia, suggested some strategies to target the C. concisus and other oral Campylobacter, two species of bacteria that most studies have identified to be key to the development Inflammatory bowel disease. Inflammatory bowel disease (IBD) is a group of chronic relapsing inflammatory diseases of the gastrointestinal tract. The cause of the condition remains poorly understood but is believed to occur in individuals with genetic predisposition when triggered by environmental factors. Evidence has shown that microbes in the gastrointestinal tract play a key role in the development of IBD. Since the bacterial species that initiate the disease remain unknown, the treatment of IBD is mainly symptomatic, involving anti-inflammation and medication that suppress the immune system. Consequently IBD relapse is common and surgery is sometimes required. As IBD is a group of diseases including Colitis and Chron’s Disease, it is important to identify initiators that are responsible for individual cases, enabling the development of treatment strategies suitable for individual patients to reduce the risk of relapse and surgery. In the review titled “Oral Campylobacter species: Initiators of a subgroup of inflammatory bowel disease? Li Zhang suggests that it is crucial for clinician
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *